Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 28, 2005; 11(12): 1854-1858
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1854
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1854
Table 5 Correlation of GF in the course of IFNα2b with RBV therapy with grade activity of inflammation and fibrosis in the liver in responders (R) and non-responders (NR). Histological classification according to Scheuer[13].
Growth factor | Inflammation activity, grading | Fibrosis hepatitis,staging | ||
Periportal | Intralobular | |||
HGF | R | NR | r = 0.4, P<0.05 | r = 0.5, P<0.05 |
NS | NS | r = 0.5, P<0.03 | r = 0.4, P<0.03 | |
EGF | R | r=–0.6, P<0.003 | r = –0.5, P<0.01 | NS |
NR | NS | NS | NS | |
TPO | R | r=0.5, P<0.01 | r = 0.6, P<0.004 | r = 0.5, P<0.01 |
NR | NS | NS | r = 0.4, P<0.04 | |
PDGF | R | r=–0.5, P<0.01 | r = –0.5, P<0.02 | NS |
NR | NS | NS | NS |
- Citation: Anatol P, Robert F, Danuta P. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1854-1858
- URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1854.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i12.1854